This multi-receptor activity distinguishes it from earlier agents such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1/GIP agonist)
Now, with GLP-1s, our aim is combination therapy that drives metabolic recalibration and metabolic resilience via medication plus healthy habits
So new data can also appear during the gap between decisions by the two agencies, and certainly approvals in the EU can take a lot longer than in the US
Start your intake How Tirzepatide Works in Your Body Tirzepatide activates receptors in your brain, pancreas, and gut that control hunger signals and glucose metabolism
Particular attention is needed for insulin and sulfonylureas (hypoglycemia risk), oral contraceptives (reduced absorption), thyroid medications (altered absorption timing), and blood thinners (variable absorption)